GERMANY Bayer MaterialScience (BMS) is bringing to a close work on carbon nanotubes it has been carrying out with external partners over the past several years after concluding that commercialisations related to its own businesses were not likely in the foreseeable future. The 30 people employed in the area are expected to be transferred to other positions within the group. "We remain convinced that carbon nanotubes have huge potential," said BMS chief executive Patrick Thomas. "It has been found, however, that the potential areas of application that once seemed promising from a technical standpoint are currendy either very fragmented or have few overlaps with the company's core products and their application spectrum." Thomas continued: "For Bayer MaterialScience, ground-breaking applications for the mass market relating to our own portfolio are not likely in the foreseeable future."
展开▼
